Skip to content

Author

Shu-Long Jiang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Tumor-derived amyloid-β drives TREM2+ macrophages immunosuppression in cholangiocarcinoma.

Cholangiocarcinoma (CCA) is an aggressive malignancy with limited therapeutic options. In this study, we explored the role of TREM2+ tumor-associated macrophages (TAMs) in modulating the immune microenvironment and their impact on anti-PD-1 therapy. Using single-cell RNA sequencing data and immunohistochemical analysis...

Xian-Ying Li, Rui-Kun Qian, Yi-Chun Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.